{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:37:57Z","timestamp":1790534277972,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T00:00:00Z","timestamp":1327881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,30]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Bone marrow-derived mesenchymal stromal cells (BM-MSCs) have immunosuppressive properties and have been used to treat steroid-refractory acute graft-versus-host disease (GVHD) in stem cell transplant patients. Cells with similar capacities can also be found in term placental tissue. We have isolated stromal cells from term fetal membrane (FMSCs), umbilical cords (UCSCs) and placental villi (PVSCs) as well as from bone marrow and compared their immunoregulatory capacity in allogeneic settings. We found that FMSCs and UCSCs suppressed proliferation significantly in mixed lymphocyte reactions (MLRs), whereas PVSCs showed inconsistent suppressive effects. When added to MLR cultures, FMSCs suppressed the production of interferon (IFN)-\u03b3 and interleukin (IL)-17, whereas UCSCs and PVSCs promoted the production of IL-17 instead. Secretion of IL-10 was increased after addition of FMSCs and UCSCs. In this setting, BM-MSCs had no significant effect on secretion of IFN-\u03b3, IL-17 or IL-10 in MLR cultures. When analysing the expression of adhesion markers, we noted that FMSCs expressed the highest levels of CD29 (\u03b21), CD49d (\u03b14) and CD54 (ICAM-1) compared to the other types of stromal cells. Thus, our data indicate that stromal cells isolated from term fetal membrane have great immunosuppressive capacity in terms of proliferation and production of proinflammatory cytokines from alloreactive T cells, and also promote anti-inflammatory IL-10. They express high levels of integrins that may be of importance in homing to inflamed tissues. Fetal membrane may provide a valuable source of cells with immunosuppressive properties and could possibly be used for treatment of acute GVHD and other inflammatory disorders.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2011.04540.x","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T14:36:45Z","timestamp":1322836605000},"page":"543-555","source":"Crossref","is-referenced-by-count":86,"title":["Stromal cells from term fetal membrane are highly suppressive in allogeneic settings <i>in vitro<\/i>"],"prefix":"10.1093","volume":"167","author":[{"given":"H","family":"Karlsson","sequence":"first","affiliation":[{"name":"Division of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Erkers","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nava","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ruhm","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Westgren","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Ringd\u00e9n","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Center for Allogeneic Stem Cell Transplantation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,30]]},"reference":[{"key":"2021122708460910100_b1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","article-title":"One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood"},{"key":"2021122708460910100_b2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation","volume":"345","author":"Hoogerbrugge","year":"1995","journal-title":"Lancet"},{"key":"2021122708460910100_b3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"key":"2021122708460910100_b4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"2021122708460910100_b5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2021122708460910100_b6","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.0902023","article-title":"Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression","volume":"184","author":"Ren","year":"2010","journal-title":"J Immunol"},{"key":"2021122708460910100_b7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"2021122708460910100_b8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"2021122708460910100_b9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/sj.leu.2404833","article-title":"Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon","volume":"21","author":"Ringden","year":"2007","journal-title":"Leukemia"},{"key":"2021122708460910100_b10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/1744666X.2.3.457","article-title":"Immune cells and molecules in pregnancy: friends or foes to the fetus?","volume":"2","author":"Mincheva-Nilsson","year":"2006","journal-title":"Expert Rev Clin Immunol"},{"key":"2021122708460910100_b11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni1317","article-title":"Mother's little helpers: mechanisms of maternal\u2013fetal tolerance","volume":"7","author":"Trowsdale","year":"2006","journal-title":"Nat Immunol"},{"key":"2021122708460910100_b12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ajog.2006.01.101","article-title":"Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration","volume":"194","author":"Portmann-Lanz","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"2021122708460910100_b13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1634\/stemcells.2007-0594","article-title":"Concise review: isolation and characterization of cells from human term placenta: outcome of the first International Workshop on Placenta Derived Stem Cells","volume":"26","author":"Parolini","year":"2008","journal-title":"Stem Cells"},{"key":"2021122708460910100_b14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-213X-7-11","article-title":"Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro","volume":"7","author":"Alviano","year":"2007","journal-title":"BMC Dev Biol"},{"key":"2021122708460910100_b15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jnr.20257","article-title":"Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells","volume":"78","author":"Sakuragawa","year":"2004","journal-title":"J Neurosci Res"},{"key":"2021122708460910100_b16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1634\/stemcells.2006-0286","article-title":"Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys","volume":"25","author":"Karahuseyinoglu","year":"2007","journal-title":"Stem Cells"},{"key":"2021122708460910100_b17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.placenta.2008.09.009","article-title":"Human fetal membranes: a source of stem cells for tissue regeneration and repair?","volume":"30","author":"Ilancheran","year":"2009","journal-title":"Placenta"},{"key":"2021122708460910100_b18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/BCR.0b013e31818b9e40","article-title":"The role of allogenic amniotic membrane in burn treatment","volume":"29","author":"Kesting","year":"2008","journal-title":"J Burn Care Res"},{"key":"2021122708460910100_b19","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1634\/stemcells.2006-0071","article-title":"Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma","volume":"24","author":"Chang","year":"2006","journal-title":"Stem Cells"},{"key":"2021122708460910100_b20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.humimm.2008.10.016","article-title":"Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells","volume":"70","author":"Roelen","year":"2009","journal-title":"Hum Immunol"},{"key":"2021122708460910100_b21","first-page":"Unit 1E","article-title":"Isolation of human placenta-derived multipotent cells and in vitro differentiation into hepatocyte-like cells","volume":"Chapter 1","author":"Huang","year":"2007","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"2021122708460910100_b22","first-page":"Unit 1E 3","article-title":"Isolation of amniotic epithelial stem cells","volume":"Chapter 1","author":"Miki","year":"2007","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"2021122708460910100_b23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp Hematol"},{"key":"2021122708460910100_b24","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/eji.200839070","article-title":"M-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells","volume":"39","author":"Guo","year":"2009","journal-title":"Eur J Immunol"},{"key":"2021122708460910100_b25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"key":"2021122708460910100_b26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"2021122708460910100_b27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","article-title":"Immunomodulation by mesenchymal stem cells and clinical experience","volume":"262","author":"Le Blanc","year":"2007","journal-title":"J Intern Med"},{"key":"2021122708460910100_b28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a Phase I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"2021122708460910100_b29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/ten.2006.0313","article-title":"Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue","volume":"13","author":"Wolbank","year":"2007","journal-title":"Tissue Eng"},{"key":"2021122708460910100_b30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/01.TP.0000144606.84234.49","article-title":"Engraftment potential of human amnion and chorion cells derived from term placenta","volume":"78","author":"Bailo","year":"2004","journal-title":"Transplantation"},{"key":"2021122708460910100_b31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1634\/stemcells.2007-0491","article-title":"Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities","volume":"26","author":"Magatti","year":"2008","journal-title":"Stem Cells"},{"key":"2021122708460910100_b32","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.4049\/jimmunol.1002239","article-title":"Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation","volume":"185","author":"Cutler","year":"2010","journal-title":"J Immunol"},{"key":"2021122708460910100_b33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clim.2010.01.015","article-title":"Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism","volume":"135","author":"Chen","year":"2010","journal-title":"Clin Immunol"},{"key":"2021122708460910100_b34","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.placenta.2007.07.001","article-title":"Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells","volume":"28","author":"Jones","year":"2007","journal-title":"Placenta"},{"key":"2021122708460910100_b35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(high) forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708460910100_b36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2249.2009.04069.x","article-title":"Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6","volume":"159","author":"Chen","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021122708460910100_b37","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/14653249.2010.542456","article-title":"Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation","volume":"13","author":"Tatara","year":"2011","journal-title":"Cytotherapy"},{"key":"2021122708460910100_b38","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J Immunol"},{"key":"2021122708460910100_b39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","article-title":"Regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans","volume":"226","author":"Lyakh","year":"2008","journal-title":"Immunol Rev"},{"key":"2021122708460910100_b40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-065X.1990.tb00561.x","article-title":"Structure of the integrin VLA-4 and its cell\u2013cell and cell\u2013matrix adhesion functions","volume":"114","author":"Hemler","year":"1990","journal-title":"Immunol Rev"},{"key":"2021122708460910100_b41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/scd.2007.0156","article-title":"Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta","volume":"17","author":"Brooke","year":"2008","journal-title":"Stem Cells Dev"},{"key":"2021122708460910100_b42","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.exphem.2010.05.007","article-title":"Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions","volume":"38","author":"Najar","year":"2010","journal-title":"Exp Hematol"},{"key":"2021122708460910100_b43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3727\/096368908786576507","article-title":"Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy","volume":"17","author":"Bilic","year":"2008","journal-title":"Cell Transplant"},{"key":"2021122708460910100_b44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/14653240802345804","article-title":"Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro","volume":"10","author":"Stadler","year":"2008","journal-title":"Cytotherapy"},{"key":"2021122708460910100_b45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/term.40","article-title":"Isolation and characterization of mesenchymal cells from human fetal membranes","volume":"1","author":"Soncini","year":"2007","journal-title":"J Tissue Eng Regen Med"},{"key":"2021122708460910100_b46","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","article-title":"Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta","volume":"22","author":"In 't Anker","year":"2004","journal-title":"Stem Cells"},{"key":"2021122708460910100_b47","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","article-title":"Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord","volume":"22","author":"Wang","year":"2004","journal-title":"Stem Cells"},{"key":"2021122708460910100_b48","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/scd.2007.0154","article-title":"Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells","volume":"17","author":"Barlow","year":"2008","journal-title":"Stem Cells Dev"},{"key":"2021122708460910100_b49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/scd.2010.0308","article-title":"Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells","volume":"20","author":"Pilz","year":"2011","journal-title":"Stem Cells Dev"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2011.04540.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/167\/3\/543\/41908128\/j.1365-2249.2011.04540.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/167\/3\/543\/41908128\/j.1365-2249.2011.04540.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:23:50Z","timestamp":1641054230000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/167\/3\/543\/6422846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,30]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,1,30]]},"published-print":{"date-parts":[[2012,1,30]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04540.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,1,30]]}}}